PerAspera Holdings Ltd. announces Adastra Labs hires Donald Dinsmore, MScPB as Alternate Quality Assurance Person for its lower mainland facility

July 13th, 2018 – PerAspera Holdings Ltd. (“PerAspera” or the “Company”) announces Adastra Labs hires  Donald Dinsmore, MScPB as Alternate Quality Assurance Person for its lower mainland facility. Managing Director Andy Hale stated, “With a Masters in Plant Biochemistry and hands on operational experience in the cannabis cultivation industry, Donald brings a perfect set of skills to help Adastra Labs become a cannabis extracts and concentrates leader in Canada.”

Mr. Dinsmore is a professional plant biochemist with a background working with successful research groups. He was born and raised in Calgary, Alberta where he attended the University of Calgary. During his undergraduate in Biochemistry degree he completed two research projects; one, studying the effects of heavy metals on cell membranes and the second utilizing site-directed mutagenesis to investigate the reaction mechanism of enzymes involved in opium poppy secondary metabolism. After earning his Bachelor’s degree, he completed a Master’s degree in Plant Biochemistry where he studied opium poppy metabolism and genomics under the tutelage of Dr. Peter Facchini. As part of the Genome Canada Project, Mr. Dinsmore was responsible for the analysis and creation of LC-MS/MS metabolomic databases for twenty unique alkaloid producing species. In addition, he employed a variety of genetic and biochemical techniques to identify novel genes from opium poppy. He also helped to train undergraduate students and guide their honours projects. An opportunity at Heart Rock Mountain Farms in Mendocino County, California began his career in the cannabis industry. He developed a ground-up understanding of organic cannabis farming and processing. In his time there, he moved up from farm labourer to operations manager, reporting to the head grower, where he helped lead a dynamic team to a record-breaking harvest.

Further Information

For further information, please contact:

Andy Hale, Managing Director

Email: info@perasperaholdings.ca

About PerAspera Holdings Ltd.

In Canada, PerAspera (through its wholly-owned subsidiary, Adastra Labs Inc. and Chemia Analytics Inc.) is in the application process to become a Standard Processor under the Cannabis Act administered by Health Canada, with licences to produce cannabis extracts and provide third party analytical testing services. These licences will further enable PerAspera and its subsidiaries to produce, package, sell (wholesale), and export medically focused and recreational cannabis extract and concentrate products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis extraction products are legal.

The Company’s operations includes a facility in British Columbia, Canada. The Company is developing its 13,035 square feet facility to be fully devoted to standard processing and laboratory testing by early 2019, from which it expects to produce significant amounts of cannabis oil for the Canadian wholesale medical and recreational markets.

The Company will offer a suite of unique products under several existing consumer-focused brands, including tinctures, medicinal oils, concentrates, and when legalized, gel capsules and vaporizer pens. Through acquisition of existing cannabis extraction brands and careful development of its new brands, PerAspera will be positioned to be a leader in branded, commercialized products in both the medical and adult-use markets across North America and internationally.

Duis iaculis mattis rutrum. Sed iaculis magna sit amet suscipit ornare. Nulla ornare leo a tortor aliquam, quis interdum ex tempor. Quisque ultricies consequat suscipit. Donec tincidunt tempor ornare. Praesent a enim vel augue suscipit auctor in gravida augue. Suspendisse ut libero sit amet augue molestie fringilla. Fusce molestie, velit a finibus eleifend, nibh odio sagittis est, id aliquet turpis orci quis nibh. Donec tincidunt tempor ornare. Praesent a enim vel augue suscipit auctor in gravida augue. Suspendisse ut libero sit amet augue molestie fringilla. Fusce molestie, velit a finibus eleifend, nibh odio sagittis est, id aliquet turpis orci quis nibh. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Proin gravida nibh vel velit auctor aliquet. Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequat ipsum. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper.

Scroll to Top